Evidence map›Paper›PMID 25629170›Full record

ArticlePLoS genetics2015

Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort.

Thomas J Hoffmann, Lori C Sakoda, Ling Shen, Eric Jorgenson, Laurel A Habel, Jinghua Liu, Mark N Kvale, Maryam M Asgari, Yambazi Banda, Douglas Corley and 6 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Pathogenic Germline DNA Repair Gene andJCO precision oncology · 2020
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Thomas J HoffmannDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America; Institute for Human Genetics, University of California San Francisco, San Francisco, California, United States of America.
Lori C SakodaDivision of Research, Kaiser Permanente, Northern California, Oakland, California, United States of America.
Ling ShenDivision of Research, Kaiser Permanente, Northern California, Oakland, California, United States of America.
Eric JorgensonDivision of Research, Kaiser Permanente, Northern California, Oakland, California, United States of America.
Laurel A HabelDivision of Research, Kaiser Permanente, Northern California, Oakland, California, United States of America.
Jinghua LiuInstitute for Human Genetics, University of California San Francisco, San Francisco, California, United States of America.
Mark N KvaleInstitute for Human Genetics, University of California San Francisco, San Francisco, California, United States of America.
Maryam M AsgariDivision of Research, Kaiser Permanente, Northern California, Oakland, California, United States of America.
Yambazi BandaInstitute for Human Genetics, University of California San Francisco, San Francisco, California, United States of America.
Douglas CorleyDivision of Research, Kaiser Permanente, Northern California, Oakland, California, United States of America.
Lawrence H KushiDivision of Research, Kaiser Permanente, Northern California, Oakland, California, United States of America.
Charles P QuesenberryDivision of Research, Kaiser Permanente, Northern California, Oakland, California, United States of America.
Catherine SchaeferDivision of Research, Kaiser Permanente, Northern California, Oakland, California, United States of America.
Stephen K Van Den EedenDivision of Research, Kaiser Permanente, Northern California, Oakland, California, United States of America; Department of Urology, University of California San Francisco, San Francisco, California, United States of America.
Neil RischDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America; Institute for Human Genetics, University of California San Francisco, San Francisco, California, United States of America; Division of Research, Kaiser Permanente, Northern California, Oakland, California, United States of America.
John S WitteDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America; Institute for Human Genetics, University of California San Francisco, San Francisco, California, United States of America; Department of Urology, University of California San Francisco, San Francisco, California, United States of America.
Kaiser Permanente · USUniversity of California, San Francisco · US

Funding

A Resource for Genetic Epidemiology Research in Adult Health and AgingRC2AG036607 · NIA · KAISER FOUNDATION RESEARCH INSTITUTE · PI RISCH, NEIL J., SCHAEFER, CATHERINE ANN · 2009 to 2010
$24.8M
Genetic Epidemiology of Prostate Cancer Risk and ProgressionR01CA088164 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VAN DEN EEDEN, STEPHEN K., WITTE, JOHN S. · 2000 to 2015
$6.1M
Genomewide Association Study of Prostate CancerU01CA127298 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WITTE, JOHN S. · 2008 to 2012
$5.1M
Genome-wide Study of Hearing ImpairmentK01DC013300 · NIDCD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HOFFMANN, THOMAS · 2013 to 2017
$1.1M
Sequencing not required: Imputing rare variants into a cohort of 100,000 on agingR21AG046616 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HOFFMANN, THOMAS · 2013 to 2014
$433k
NCI NIH HHS R01 CA088164NCI NIH HHS U01 CA127298NIA NIH HHS R21 AG046616NIA NIH HHS RC2 AG036607NIA NIH HHS RC2AG036607NIDCD NIH HHS K01 DC013300
6 · The paper itself

Abstract

An efficient approach to characterizing the disease burden of rare genetic variants is to impute them into large well-phenotyped cohorts with existing genome-wide genotype data using large sequenced referenced panels. The success of this approach hinges on the accuracy of rare variant imputation, which remains controversial. For example, a recent study suggested that one cannot adequately impute the HOXB13 G84E mutation associated with prostate cancer risk (carrier frequency of 0.0034 in European ancestry participants in the 1000 Genomes Project). We show that by utilizing the 1000 Genomes Project data plus an enriched reference panel of mutation carriers we were able to accurately impute the G84E mutation into a large cohort of 83,285 non-Hispanic White participants from the Kaiser Permanente Research Program on Genes, Environment and Health Genetic Epidemiology Research on Adult Health and Aging cohort. Imputation authenticity was confirmed via a novel classification and regression tree method, and then empirically validated analyzing a subset of these subjects plus an additional 1,789 men from Kaiser specifically genotyped for the G84E mutation (r2 = 0.57, 95% CI = 0.37–0.77). We then show the value of this approach by using the imputed data to investigate the impact of the G84E mutation on age-specific prostate cancer risk and on risk of fourteen other cancers in the cohort. The age-specific risk of prostate cancer among G84E mutation carriers was higher than among non-carriers. Risk estimates from Kaplan-Meier curves were 36.7% versus 13.6% by age 72, and 64.2% versus 24.2% by age 80, for G84E mutation carriers and non-carriers, respectively (p = 3.4x10-12). The G84E mutation was also associated with an increase in risk for the fourteen other most common cancers considered collectively (p = 5.8x10-4) and more so in cases diagnosed with multiple cancer types, both those including and not including prostate cancer, strongly suggesting pleiotropic effects. [corrected].

Indexed as

AdultAgedAged, 80 and overCaliforniaGenetic Predisposition to DiseaseGenome-Wide Association StudyGerm-Line MutationHaplotypesHomeodomain ProteinsHumansMaleMiddle AgedPhylogenyPolymorphism, Single NucleotideProstatic NeoplasmsRisk FactorsHomeodomain ProteinsHOXB13 protein, human

Identifiers

PMID25629170
PMCPMC4309593
OpenAlexW2021272672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.